Loading…
Loading…
6919.TWO (Caliway Biopharmaceuticals Co., Ltd.) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.

| 6949.TW | Pell Bio-Med Technology Co., Ltd. | NT$1,490.00 | NT$97.7B |
| 6696.TWO | Lin BioScience, Inc. | NT$939.00 | NT$77.9B |
| 4123.TWO | Center Laboratories, Inc. | NT$32.10 | NT$24.2B |
| 4743.TWO | Oneness Biotech Co., Ltd. | NT$47.80 | NT$22.9B |
| 4728.TWO | Sunmax Biotechnology Co., Ltd. | NT$400.00 | NT$21.8B |
| 4105.TWO | TTY Biopharm Company Limited | NT$78.20 | NT$19.4B |
| 4147.TWO | TaiMed Biologics Inc. | NT$65.60 | NT$17.8B |
| 6589.TWO | EirGenix Inc. | NT$45.95 | NT$13.7B |
| 6550.TW | Polaris Group | NT$11.55 | NT$10.3B |
| 6541.TW | Tanvex BioPharma, Inc. | NT$36.80 | NT$9.8B |